Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisorThe MEG business of Elekta has been acquired by York Instruments Ltd
We advised Elekta AB on the sale of MEGIN, its MEG business, to York Instruments Ltd. Financial details have not been disclosed.
Learn moreNaturex SA has acquired Swedish Oat Fiber AB
Naturex SA, the global leader in specialty plant-based natural ingredients, has acquired Swedish Oat Fiber AB, a specialized manufacturer of oat dietary fibers, oat oils and oat proteins. Financial details have not been disclosed.
Learn moreXbrane Biosciences AB has aquired Primm Pharma
Xbrane Biosciences AB (Xbrane) has acquired Primm Pharma (Primm) for an undisclosed consideration.
Learn moreHenrik Svärdskog
CEO and Co-owner, Kungshusen Medicinska AB
Read moreBelgian radioisotope producer secures US$104.1 million to expand global production
DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.
Learn moreTalk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital